Our recent studies revealed an overexpression of MUC4 in ovarian (Chauhan et al, 2006) and pancreatic tumours (Andrianifahanana et al, 2001), whereas its expression was downregulated in prostate cancer (Singh et al, 2006). Here, MUC4 is linked to pancreatic neoplasm.